<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25-pharmaceutics-10-00039">
 <label>25.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dalpiaz</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Fogagnolo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ferraro</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Capuzzo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Pavan</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Rassu</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Salis</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Giunchedi</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Gavini</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries</article-title>
  <source>Antivir. Res.</source>
  <year>2015</year>
  <volume>123</volume>
  <fpage>146</fpage>
  <lpage>157</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.09.013</pub-id>
  <?supplied-pmid 26427553?>
  <pub-id pub-id-type="pmid">26427553</pub-id>
 </element-citation>
</ref>
